Cyclic Administration of Pamidronate in Children with Severe Osteogenesis Imperfecta

Abstract

In children with severe osteogenesis imperfecta, cyclic administration of intravenous pamidronate improved clinical outcomes, reduced bone resorption, and increased bone density.